Objective Although chronic obstructive pulmonary disease (COPD) is characterized by systemic inflammation, the association between the neutrophil to lymphocyte ratio (NLR; an indicator of inflammation) and the clinical status of COPD has not been well studied. We hypothesized that the NLR is associated with disease severity and exacerbation in COPD patients. Methods We performed blood testing, pulmonary function testing, chest computed tomography, a body composition analysis, and a 6-minute walk test and applied the modified Medical Research Council (MMRC) dyspnea scale for 141 stable COPD patients. In addition, we calculated the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index to evaluate the disease severity. Finally, we examined the association between the NLR and clinical parameters in stable COPD patients, and we further investigated changes in the NLR between exacerbation and the stable state. Results The NLR was positively correlated with the BODE index, extent of emphysema, and MMRC score (p<0.001 for all), while inversely correlated with airflow obstruction (p<0.001), body mass index (p<0.001), fat-free mass index (p=0.001), and the 6-minute walk distance (p<0.001). We obtained the NLR during exacerbation from 49 patients. The NLR was significantly higher at exacerbation compared to the stable state (p< 0.001). Conclusion The NLR was associated with disease severity and exacerbation in COPD patients. Therefore, the usefulness of the NLR in COPD patients should be elucidated in clinical settings in future investigations.
Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow obstruction associated with an enhanced chronic inflammatory response in the airways (1) . COPD is a heterogeneous disease with several clinical and physiological phenotypes (2) (3) (4) . It has been considered that systemic inflammation is associated with the COPD phenotype; however, the prevalence of systemic inflammation in COPD appears to vary depending on the markers (4) . Exacerbations are associated with the quality of life and disease progression in COPD (1, 5) . Viral or bacterial infection is one of the major causes of exacerbation, and bacterial colonization in particular is considered to be responsible for exacerbations in COPD (6) . It is possible that bacterial colonization itself, or repetitive and intermittent exacerbation caused by the colonization, may contribute to chronic airway inflammation and the progression of COPD (6) . Inflammation is a complex set of interactions among various immune-related cells, including neutrophils and lymphocytes, which can lead to persistent tissue damage if targeted Patients who meet the above criteria at the time of enrollment were not eligible for the present study. 1 Patients with clinically apparent bronchial asthma, namely patients with nighttime waking with breathlessness and wheezing, significant diurnal variation of symptoms, symptom onset <35 years, or reversibility of airflow obstruction as described in National Institute for Health and Care Excellence Guidelines 2010, were excluded. 2 Exacerbation is defined in the text.
destruction and assist repair are not properly phased (7) . COPD is a type of chronic inflammatory disease, and it is possible that the immune response of host lung defense against bacteria could cause an excessive inflammatory response, contributing to the pathological conditions of chronic inflammatory disease (6) (7) (8) . The numbers and ratio of immune-related cells in the peripheral blood have the potential to indicate the pathological condition of chronic inflammation. However, it is not clear whether inflammatory responses are based on neutrophil-dominated innate immunity or lymphocyte-dominated adaptive immunity in COPD (9) (10) (11) (12) .
More recently, an elevation in the neutrophil to lymphocyte ratio (NLR), an indicator of inflammation, has been associated with disease severity, hospitalization, malnutrition, and mortality in various chronic diseases such as cardiovascular and kidney diseases (13) (14) (15) . Regarding COPD, it has been recently reported that the NLR could be considered to be a marker for assessing inflammation because the NLR was higher in exacerbated than in stable patients (16) . However, the association between the NLR and severity of COPD, as well as changes in the NLR between stable and exacerbation states in patients, has not been well studied.
Since the degree of airflow obstruction assessed by forced expiratory volume in one second (FEV1) is not always related to clinical outcomes in COPD (1, 4) , in this study we assessed disease severity using the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index, a multidimensional grading system that predicts mortality, hospitalization, and risk of exacerbation and reflects detrimental changes that occur during exacerbation in COPD (17) (18) (19) (20) .
We hypothesized that the NLR is associated with disease severity and increased during exacerbation since bacterial colonization increases as COPD becomes more severe. To test this hypothesis, we examined the association between the NLR, a composite indicator of neutrophils and lymphocytes which are involved in COPD inflammation, and disease severity in stable COPD patients. We further explored changes in the NLR between stable and exacerbation states in individual COPD patients.
Materials and Methods

Subjects
Between January 2009 and December 2011, we recruited stable COPD outpatients aged 40 years or older (n=141), who were current or ex-smokers, at the Respiratory Care Clinic, Nippon Medical School, Tokyo, Japan. The diagnosis of COPD was made according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) documents (1) . Of the 141 patients, we retrospectively included 41 patients with both a history of COPD exacerbations and data for blood tests that were essential for the present study to identify any changes in the NLR between stable and exacerbated states in individual COPD patients. Detailed exclusion criteria are provided in Table 1 . This study was approved by the Ethics Committee of Nippon Medical School, and all patients were enrolled after they had provided their written informed consent.
Exacerbations
An exacerbation of COPD was defined as an onset or worsening of more than two respiratory symptoms (i.e., dyspnea, sputum amount or purulence, or a cough or wheeze) for two or more consecutive days. The date of onset and sputum amount or purulence was determined once a month according to an interview (diary and self-assessment) during the patient's visit to our clinic (21) . A stable state was defined as no symptoms of exacerbation and no use of systemic corticosteroids and/or antibiotics for the preceding 8 weeks.
Measurements
Pulmonary functional parameters, including postbronchodilator FEV1, carbon monoxide diffusing capacity, vital capacity, and forced vital capacity, were measured according to the American Thoracic Society guidelines (22) using computer-coupled equipment for lung function testing (Chestac; Chest M.I., Tokyo, Japan). Post-bronchodilator reference values were based on the standards of the Japanese Respiratory Society (23). Airflow obstruction severity 61.9 ± 9.14 Total lymphocyte count (×10 The body mass index (BMI) was calculated as the ratio of body weight to height (kg/m 2 ). Fat-free mass (FFM) and fat mass (FM) were measured using a bioelectrical impedance analysis at 5, 50, 250, and 500 kHz frequencies (InBody 3.2; Biospace, Seoul, Republic of Korea). The fat-free mass index (FFMI) and fat mass index (FMI) were calculated as the ratio of FFM or FM to height (kg/m 2 ), respectively. The degree of dyspnea was assessed using the Modified Medical Respiratory Council (MMRC) dyspnea scale (24) . The MMRC score ranges from 0 to 4 and increases with the severity of dyspnea.
The 6-minute walk distance (6MWD) test was performed according to the standards of the American Thoracic Society (25) . Oximetry was performed at 10-second intervals with a pulse oximeter during the test (PULSOX; Teijin Pharma, Tokyo, Japan).
The BODE index was calculated using the BMI, 6MWD, %FEV1, and the MMRC scale as described previously (17) . The total score ranges from 0 to 10 points, and a high BODE score indicates a high risk of death.
The extent of emphysema was determined using the percentage of low-attenuation area (LAA%), as described previously (26) , in high-resolution computed tomography (CT) images obtained using a Light Speed Pro 16 CT scanner (GE Healthcare Japan, Tokyo, Japan) with the following settings: 1.25 mm collimation, 0.8 second scan time (rotation time), 120 kV, and 100-600 mA.
Peripheral blood samples were collected from all subjects during the daytime. All laboratory tests, including differential counts of leukocytes, such as neutrophils and lymphocytes, and high-sensitivity C-reactive protein (CRP) were determined at the BML General Laboratory (BML, Tokyo, Japan). The NLR was defined as the absolute neutrophil count divided by the absolute lymphocyte count. CRP was assessed by nephelometry using the N-latex CRP II CardioPhase hsCRP reagent (Siemens Health Care Diagnostics, Tokyo, Japan).
The degree of comorbidity was determined using the Charlson index (27) , which is associated with mortality in COPD (28) . We used the "International Classification of Diseases 10th Revision" coding algorithms for Charlson comorbidities (29) .
Statistical analysis
The Shapiro-Wilk test was used to determine the normal distribution. Relationships between the blood markers and clinical parameters were evaluated using the Pearson correlation coefficient or the Spearman rank correlation coefficient, depending on the data distribution. We used a forced entry multiple linear regression analysis to determine adjusted relations for age, sex, comorbidities, and the smoking status (pack-years and current or former smoker). Dependent variables of multiple linear regression models were lognormalized before regression analyses as needed. Differences between paired samples in the same subjects were analyzed using the Wilcoxon matched-pairs signed rank test. Statistical significance was determined to exist at p<0.05 with a two-tailed test. The PASW statistics version 18.0.0 for Windows software package (IBM, New York, USA) was used for all data analyses.
Results
Characteristics of the patients
The main characteristics of the patients in a state are shown in Table 2 . The patients included in this study (n= 141) had a mean age of 71.2 years. The study group was characterized by moderate to severe COPD, a normal BMI, and low FFMI. The majority of patients (97.1%) were men. Out of the 141 patients, we obtained a NLR during both exacerbation and stable states from 49 subjects (mean age = 71.9 years; Supplementary material). Charlson comorbidities of the stable patients are shown in Table 3 .
The neutrophil to lymphocyte ratio and clinical parameters
We found that the NLR was significantly correlated with %FEV1 (rho =-0.387, p<0.001; Fig. 1 ) and the BODE index (rho =0.465, p<0.001; Fig. 2 ). There was also a significant correlation between the NLR and the LAA% (rho =0.322, p<0.001), BMI (rho =-0.268, p=0.001), FFMI (rho =-0.355, The association between NLR and clinical parameters remained significant after adjusting for age, sex, the Charlson index, and smoking status (%FEV1 p<0.001; BODE index p<0.001; LAA% p<0.001; BMI p=0.011; FFMI p=0.001; 6MWD p<0.001; MMRC score p<0.001).
The total neutrophil and lymphocyte count and clinical parameters
The total neutrophil count was significantly correlated with %FEV1, the BODE index, LAA%, FFMI, 6MWD, and the MMRC score, but not with the FMI or BMI. The total lymphocyte count was significantly correlated with %FEV1, the BODE index, BMI, FFMI, 6MWD, and MMRC score, but not with the FMI or LAA%. These associations remained significant after adjusting for age, sex, the Charlson index, and smoking status (data not shown).
C-reactive protein and clinical parameters
There was a significant association between the CRP levels and the NLR (rho =0.209, p=0.015). The CRP levels were also significantly associated with the BODE index (rho =0.199, p=0.022) and MMRC score (rho =0.187, p=0.031) ( Table 5 ). The association between the CRP levels and the NLR remained significant after adjusting for age, sex, the Charlson index, and smoking status (p=0.027), but not the BODE index (p=0.150) or MMRC score (p=0.283).
The neutrophil to lymphocyte ratio and C-reactive protein during exacerbation
During exacerbation, the NLR was significantly elevated compared to the stable state (p<0.001; Fig. 3 ). In addition, the CRP levels during exacerbation were also significantly elevated compared to the stable state (p=0.004; Fig. 4 ).
Discussion
In our study, we showed that an increased NLR was observed in stable COPD patients with severe airflow obstruction, high BODE scores, and severe emphysema. Furthermore, the NLR was higher during exacerbations than in the stable state in some COPD patients.
Our study yielded several interesting findings. First, the NLR increased with the severity of airflow obstruction and emphysematous change, suggesting that the NLR may reflect the extent of airflow obstruction as a pulmonary functional phenotype and the extent of emphysematous change as a structural phenotype in COPD. Although the underlying mechanism associated between the NLR and COPD has not been clearly established, it is possible that neutrophils play an important role, since neutrophil inflammation is a prominent feature of COPD. In the course of inflammation, activated neutrophils cause tissue destruction in lungs by releasing oxygen radicals and proteolytic enzymes such as neutrophil elastase and matrix metalloproteinases, which ultimately results in emphysema (12, 30, 31) . Emphysematous change may lead to chronic airway obstruction when combined with small airway disease (1). The neutrophil-mediated response also contributes to the severity of airway obstruction (32) . The extent of inflammation in small airways is associated with the extent of airflow obstruction in COPD (33) . A previous study also showed that systemic biomarkers of neutrophil inflammation are associated with COPD severity as reflected in the GOLD stages (34) .
Second, it is also interesting to note that the NLR was associated with the BODE index, a multidimensional assess-ment system. In our study, we found that the NLR was associated with all components of the BODE index, indicating that an increased NLR was associated not only with airflow obstruction, but also with other factors such as malnutrition, impaired exercise capacity, and worsening of dyspnea. Immune dysregulation of peripheral blood in COPD patients may contribute to extrapulmonary effects (12) . It has also been speculated that the NLR is associated with the prognosis and/or an exacerbation in COPD since the BODE index is associated with the risk of exacerbation (20) . Indeed, we found that the NLR during exacerbation in COPD patients was higher compared to the stable state. This might be related to the fact that bacterial exacerbation leads to increased airway and systemic inflammation (6) . A previous study showed that the NLR was higher in exacerbated COPD patients compared to stable patients, although changes in the NLR in an individual during the stable and exacerbation states have not been studied (16) . Tanriverdi et al. showed that the NLR could predict bacterial infection in hospitalized COPD patients with acute exacerbation (35) . Other studies have shown that the NLR can predict bacteremia or the severity of community-acquired pneumonia with a higher prognostic accuracy than traditional infection parameters, including CRP (36, 37) . Patients with elevated NLR have relative neutrophilia and lymphocytopenia. Neutrophilia is well recognized as a marker of infection, while the potential of lymphocytopenia as a predictor for bacteremia or the severity of infectious diseases is less recognized (37) . Indeed, in our study, the total neutrophil count exhibited significant associations with various COPD clinical parameters similar to the NLR except that the NLR was also significantly associated with the BMI. Additionally, there were significant associations between the total lymphocyte count and various clinical parameters as observed for the NLR, although the NLR was also significantly associated with the extent of emphysematous change. Thus, the combination of neutrophils and lymphocytes in a single composite indicator (i.e., the NLR), can potentially provide more powerful information regarding the clinical status of COPD patients than a single parameter alone.
Third, we found that the NLR was not associated with the Charlson index in this study. The pathogenic mechanisms underlying comorbidities in COPD remain unclear. Classically, it has been hypothesized that spilling of inflammatory mediators from the lung to the systemic circulation contributes to the development of comorbidities in COPD patients (38) . On the other hand, the new concept of "multimorbidity" in COPD patients has gained attention, in which COPD is just one coexistent disease in a multi-morbid condition with common risk factors such as smoking, inactivity, and age (39) (40) (41) . In this concept, various chronic diseases may have synergistic effects on the overall health status; thus, the multi-morbid conditions and their risk factors could interact with, and influence, the NLR in this study. Taking into account this new concept and the findings of our study, we speculate that not only systemic inflammation, but also other factors such as age may cause comorbidities in COPD patients. However, it is important to note that the Charlson index includes only some diseases; thus, in this study, we could not assess the influence of COPD on comorbidities that are not included in the Charlson index.
The NLR appears to have several advantages for the characterization of COPD because it is a simple, inexpensive, and easily obtainable indicator. Since the NLR is associated with the BODE index, it may provide useful information without the need for performing several tests in primary care settings. We also found that the NLR was higher in patients during COPD exacerbation than in stable states. However, we only observed associations between the distribution of the NLR and disease severity and exacerbation. The usefulness of the NLR in COPD patients should be elucidated in clinical settings in future studies. Indeed, previous research showed that the NLR is associated with mortality in COPD patients (42) .
There are some limitations associated with our study. First, the population size was relatively small, and we did not include a healthy control group. Second, this was a cross-sectional study. Third, we did not set a specific blood sampling time, although circadian variations in circulating neutrophil and lymphocyte counts have been reported (43, 44) . We only set a minimum standard that the blood samples should be obtained during the daytime. Blood sampling times and conditions should be standardized in future investigations. Finally, we could not completely exclude the effect of comorbid conditions. In general, the NLR might be influenced by various factors, including systemic infections, atherosclerosis, hypertension, chronic renal disease and diabetes, and it can also be affected by atherosclerosis risk factors such as smoking, alcohol consumption, metabolic syndrome, and hypercholesterolemia (45) . Although some of those conditions were adjusted for or excluded, we could not completely discard all comorbid conditions that might influence the NLR.
Conclusion
The NLR was associated with disease severity and exacerbation in COPD patients. The usefulness of the NLR in COPD patients should therefore be further elucidated in clinical settings in future investigations.
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